RXST Q3 2025 Earnings — RxSight, Inc. Revenue & Financial Results | Market Cap Arena

RXSTRxSight, Inc.

$313M

Q3 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$30M-33.2% YoY

Gross Profit

$24M79.9% margin

Operating Income

-$12M-40.1% margin

Net Income

-$10M-32.4% margin

EPS (Diluted)

$-0.24

QoQ Revenue Growth

-9.8%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$2M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$309M

Total Liabilities

$33M

Stockholders' Equity

$276M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$30M	$45M	-33.2%
Gross Profit	$24M	$25M	-3.9%
Operating Income	-$12M	-$9M	-32.0%
Net Income	-$10M	-$6M	-54.9%

Revenue Segments

L D D

$3M68%

Service Warranty Service Contracts And Accessories

$1M32%